Share on StockTwits

Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the company’s stock on the open market in a transaction dated Friday, June 27th. The shares were sold at an average price of $171.65, for a total transaction of $360,465.00. Following the transaction, the director now directly owns 12,466 shares of the company’s stock, valued at approximately $2,139,789. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

A number of analysts have recently weighed in on ILMN shares. Analysts at Zacks upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Tuesday. They now have a $205.00 price target on the stock. Separately, analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Finally, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. Illumina has an average rating of “Buy” and an average price target of $146.71.

Illumina (NASDAQ:ILMN) traded up 1.01% on Friday, hitting $172.70. The stock had a trading volume of 957,110 shares. Illumina has a 52-week low of $72.13 and a 52-week high of $183.30. The stock has a 50-day moving average of $162.0 and a 200-day moving average of $146.9. The company has a market cap of $22.175 billion and a P/E ratio of 120.24. Illumina also was the recipient of a significant decrease in short interest during the month of June. As of June 13th, there was short interest totalling 10,265,824 shares, a decrease of 41.3% from the May 30th total of 17,495,888 shares. Currently, 8.1% of the company’s stock are short sold. Based on an average daily trading volume, of 2,518,211 shares, the days-to-cover ratio is currently 4.1 days.

Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, April 22nd. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the prior year, the company posted $0.46 earnings per share. The company’s quarterly revenue was up 27.2% on a year-over-year basis. On average, analysts predict that Illumina will post $2.17 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.